AZZ Inc

AZZ remains in a Stage 4 decline with a clear lower-high and lower-low sequence under declining short-term EMAs and distribution-biased volume. Medium-term bias is firmly bearish with no active patterns to suggest a reversal, and short-term rejection at the 9/21 EMA and 50-day EMA confluence provides a tactical sell-now signal.

• ↑Q1 2027 revenue rose 6.3% YoY to $448.5M with adjusted EPS of $1.85, topping estimates
• ↑Full-year 2027 sales outlook upped to $1.80–1.85B, signaling sustained end-market demand
• ↓Shares trade about 73% above intrinsic value, with negative Book/Price score reflecting stretched valuation